May 16, 2026
Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025 0
By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...
Read More Read more about Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation modernas-mrna-flu-vaccine-shows-superior-efficacy-navigates-fda-review-after-initial-hesitation

Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation

Ammar Sabilarrohman August 13, 2025 0
A groundbreaking Phase III trial has demonstrated that Moderna’s experimental mRNA-based flu vaccine, mRNA-1010, significantly outperforms a...
Read More Read more about Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation
Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities japan-faces-uphill-battle-to-achieve-lung-cancer-screening-goals-amidst-persistent-regional-and-gender-disparities

Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities

Raul Delapena Setiawan August 13, 2025 0
Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening...
Read More Read more about Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities
Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition funding-at-a-crossroads-metavivor-outlines-high-stakes-in-fy-2027-budget-battle-and-cdc-leadership-transition

Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

Nana Muazin August 11, 2025 0
WASHINGTON, D.C. — As the cherry blossoms reached their peak in the nation’s capital this April, the...
Read More Read more about Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

You may have missed

the-crush-initiative-assessing-the-federal-governments-aggressive-new-stance-on-medicaid-fraud

The CRUSH Initiative: Assessing the Federal Government’s Aggressive New Stance on Medicaid Fraud

Lina Hope May 16, 2026 0
advancing-the-frontier-of-metastatic-breast-cancer-research-metavivor-announces-2026-grant-cycle-and-new-clinical-directions

Advancing the Frontier of Metastatic Breast Cancer Research: METAVIVOR Announces 2026 Grant Cycle and New Clinical Directions

Rifan Muazin May 16, 2026 0
empowering-the-mbc-community-a-february-report-on-metavivors-legislative-and-advocacy-momentum

Empowering the MBC Community: A February Report on METAvivor’s Legislative and Advocacy Momentum

Raul Delapena Setiawan May 16, 2026 0
the-new-pilgrimage-why-mexico-is-redefining-the-global-wellness-landscape

The New Pilgrimage: Why Mexico is Redefining the Global Wellness Landscape

Suro Senen May 16, 2026 0